Endovia Health Sciences (EDVA) vs Oragenics (OGEN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Oragenics is the larger company by market cap ($2.1 million vs $1.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EDVA | OGEN |
|---|---|---|
| Share price | $0.1599 | $0.463 |
| Market cap | $1.77M | $2.09M |
| 1-day change | -3.09% | -7.38% |
| EPS (TTM) | $-21.94 | $-2.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.40 | $1.45 |
| 52-week low | $0.15 | $0.46 |
| Distance from 52-week high | -98.81% | -68.07% |
| Average volume | 4.50M | 28.96K |
| Shares outstanding | 11.08M | 4.51M |
| Employees | 1 | 3 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Endovia Health Sciences
EDVA stock →Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America.
Healthcare · Biotechnology · 1 employees
About Oragenics
OGEN stock →Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury.
Healthcare · Biotechnology · 3 employees
EDVA vs OGEN FAQ
Which is bigger, Endovia Health Sciences or Oragenics?
Oragenics (OGEN) is larger, with a market capitalization of $2.09M compared with $1.77M for Endovia Health Sciences (EDVA).
Are Endovia Health Sciences and Oragenics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.